Literature DB >> 20810573

Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study.

Jasmin Divers1, Lynne E Wagenknecht, Donald W Bowden, J Jeffrey Carr, R Caresse Hightower, Thomas C Register, Jianzhao Xu, Carl D Langefeld, Barry I Freedman.   

Abstract

BACKGROUND: Calcified atherosclerotic plaque (CP) is less prevalent and less severe in African-Americans (AA), relative to European Americans (EA). Because pericardial adipose tissue (PAT) is associated with CP in the neighboring coronary arteries, we explored ethnic-specific relationships between PAT and CP.
METHODS: PAT volume and coronary and aortic CP were measured in 561 EA and 575 AA subjects with type 2 diabetes using single and multidetector computed tomography. Generalized estimating equations with exchangeable correlation and the sandwich estimator of the variance were used to test for associations between PAT and CP.
RESULTS: Mean (sd) ages of AA and EA participants were 56.7 (9.5) and 62.0 (8.9) yr, respectively; diabetes duration was 10.5 (8.1) and 10.1 (7.3) yr; and PAT volume was 86.9 (38.6) and 131.7 (55.3) cm3/45 mm. In AA and EA participants, respectively, mean (sd) coronary CP mass scores were 803 (1,889) and 1,465 (2,847) mg calcium; and aortic CP, 5,407 (10,651) and 10,090 (15,087) mg calcium. Adjusting for age, gender, body mass index, blood pressure, height, smoking, lipid-lowering medications, C-reactive protein, albuminuria, high-density lipoprotein-cholesterol, and triglycerides, parameter estimates for the relationship between PAT and log(coronary CP+1) were 0.012 in AA (P<0.0001) and 0.003 (P=0.24) in EA, with a significant ethnic difference (P=0.019). No significant relationships or ethnic differences were observed between PAT and aortic CP (P=0.24, fully adjusted model).
CONCLUSIONS: Pericardial adiposity is strongly associated with coronary atherosclerosis in AA with type 2 diabetes. Novel cardiovascular disease risk factors such as PAT may contribute to ethnic disparities in susceptibility to development of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810573      PMCID: PMC2999975          DOI: 10.1210/jc.2010-0793

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Weight of pericardial fat on coronaropathy.

Authors:  Karine Clément; Arnaud Basdevant; Anne Dutour
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-05       Impact factor: 8.311

2.  Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy.

Authors:  Alina Silaghi; Marie-Dominique Piercecchi-Marti; Michel Grino; Georges Leonetti; Marie C Alessi; Karine Clement; Frederic Dadoun; Anne Dutour
Journal:  Obesity (Silver Spring)       Date:  2008-08-14       Impact factor: 5.002

3.  The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jingzhong Ding; Fang-Chi Hsu; Tamara B Harris; Yongmei Liu; Stephen B Kritchevsky; Moyses Szklo; Pamela Ouyang; Mark A Espeland; Kurt K Lohman; Michael H Criqui; Matthew Allison; David A Bluemke; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

4.  Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis.

Authors:  Martin Greif; Alexander Becker; Franz von Ziegler; Corinna Lebherz; Michael Lehrke; Uli C Broedl; Janine Tittus; Klaus Parhofer; Christoph Becker; Maximilian Reiser; Andreas Knez; Alexander W Leber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-19       Impact factor: 8.311

5.  Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease.

Authors:  Masaaki Konishi; Seigo Sugiyama; Koichi Sugamura; Toshimitsu Nozaki; Keisuke Ohba; Junichi Matsubara; Yasushi Matsuzawa; Hitoshi Sumida; Yasuhiro Nagayoshi; Takeshi Nakaura; Kazuo Awai; Yasuyuki Yamashita; Hideaki Jinnouchi; Kunihiko Matsui; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

6.  Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study.

Authors:  Amir A Mahabadi; Joseph M Massaro; Guido A Rosito; Daniel Levy; Joanne M Murabito; Philip A Wolf; Christopher J O'Donnell; Caroline S Fox; Udo Hoffmann
Journal:  Eur Heart J       Date:  2009-01-09       Impact factor: 29.983

7.  Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis.

Authors:  Jingzhong Ding; Stephen B Kritchevsky; Fang-Chi Hsu; Tamara B Harris; Gregory L Burke; Robert C Detrano; Moyses Szklo; Michael H Criqui; Matthew Allison; Pamela Ouyang; Elizabeth R Brown; J Jeffrey Carr
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

8.  Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis.

Authors:  Chao-Ping Wang; Hui-Ling Hsu; Wei-Chin Hung; Teng-Hung Yu; Yen-Hsun Chen; Cheng-An Chiu; Li-Fen Lu; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-05       Impact factor: 3.478

9.  Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis.

Authors:  Christina L Wassel; James S Pankow; Carmen A Peralta; Shweta Choudhry; Michael F Seldin; Donna K Arnett
Journal:  Circ Cardiovasc Genet       Date:  2009-09-19

10.  Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study.

Authors:  Jasmin Divers; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; Jianzhao Xu; Carl D Langefeld; Barry I Freedman
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more
  12 in total

1.  Relationships between measures of adiposity with subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Mingxia Yuan; Fang-Chi Hsu; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Mary E Comeau; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Carl D Langefeld; Barry I Freedman
Journal:  Obesity (Silver Spring)       Date:  2016-06-29       Impact factor: 5.002

Review 2.  [Identification and quantification of fat compartments with CT and MRI and their importance].

Authors:  C L Schlett; U Hoffmann
Journal:  Radiologe       Date:  2011-05       Impact factor: 0.635

3.  Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetes.

Authors:  Jasmin Divers; Christina Hugenschmidt; Kaycee M Sink; Jeffrey D Williamson; Yaorong Ge; S Carrie Smith; Donald W Bowden; Christopher T Whitlow; Eric Lyders; Joseph A Maldjian; Barry I Freedman
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-05-16       Impact factor: 2.136

4.  Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.

Authors:  A J Cox; M R Wing; J J Carr; R C Hightower; S C Smith; J Xu; L E Wagenknecht; D W Bowden; B I Freedman
Journal:  Diabetes Metab       Date:  2011-06-14       Impact factor: 6.041

Review 5.  Effect of race and genetics on vitamin D metabolism, bone and vascular health.

Authors:  Barry I Freedman; Thomas C Register
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

Review 6.  Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.

Authors:  Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr
Journal:  Rev Diabet Stud       Date:  2010-11-10

7.  Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes.

Authors:  Jasmin Divers; Thomas C Register; Carl D Langefeld; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; Jianzhao Xu; Keith A Hruska; Barry I Freedman
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

8.  Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes.

Authors:  Fang-Chi Hsu; Mingxia Yuan; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Carl D Langefeld; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Jeff D Williamson; Kaycee M Sink; Joseph A Maldjian; Barry I Freedman
Journal:  J Diabetes Complications       Date:  2016-08-19       Impact factor: 2.852

9.  Albuminuria associates with calcified atherosclerotic plaque in African Americans with diabetes.

Authors:  Jasmin Divers; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; S Carrie Smith; Jianzhao Xu; Carl D Langefeld; Barry I Freedman
Journal:  Diabetes Care       Date:  2013-03       Impact factor: 19.112

10.  An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects.

Authors:  Lijun Ma; Mariana Murea; James A Snipes; Alejandra Marinelarena; Jacqueline Krüger; Pamela J Hicks; Kurt A Langberg; Meredith A Bostrom; Jessica N Cooke; Daisuke Suzuki; Tetsuya Babazono; Takashi Uzu; Sydney C W Tang; Ashis K Mondal; Neeraj K Sharma; Sayuko Kobes; Peter A Antinozzi; Matthew Davis; Swapan K Das; Neda Rasouli; Philip A Kern; Nathan J Shores; Lawrence L Rudel; Matthias Blüher; Michael Stumvoll; Donald W Bowden; Shiro Maeda; John S Parks; Peter Kovacs; Robert L Hanson; Leslie J Baier; Steven C Elbein; Barry I Freedman
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.